NCT04261413 2026-03-11
Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors
RS Arastirma Egitim Danismanlik Ilac Sanayi Ticaret A.S.
Phase 1 Completed
RS Arastirma Egitim Danismanlik Ilac Sanayi Ticaret A.S.
Boehringer Ingelheim
Hoffmann-La Roche
Xinqiao Hospital of Chongqing